30480234|t|Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease.
30480234|a|Diverse pathogens are detected in Alzheimer's disease (AD) brains. A bioinformatics survey showed that AD genome-wide association study (GWAS) genes (localized in bone marrow, immune locations and microglia) relate to multiple host/pathogen interactomes (Candida albicans, Cryptococcus neoformans, Bornavirus, Borrelia burgdorferri, cytomegalovirus, Ebola virus, HSV-1, HERV-W, HIV-1, Epstein-Barr, hepatitis C, influenza, Chlamydia pneumoniae, Porphyrymonas gingivalis, Helicobacter pylori, Toxoplasma gondii, Trypanosoma cruzi). These interactomes also relate to the AD hippocampal transcriptome and to plaque or tangle proteins. Upregulated AD hippocampal genes match those upregulated by multiple bacteria, viruses, fungi, or protozoa in immunocompetent cells. AD genes are enriched in GWAS datasets reflecting pathogen diversity, suggesting selection for pathogen resistance, as supported by the old age of AD patients, implying resistance to earlier infections. APOE4 is concentrated in regions of high parasitic burden and protects against childhood tropical infections and hepatitis C. Immune/inflammatory gain of function applies to APOE4, CR1, and TREM2 variants. AD genes are also expressed in the blood-brain barrier (BBB), which is disrupted by AD risk factors (age, alcohol, aluminum, concussion, cerebral hypoperfusion, diabetes, homocysteine, hypercholesterolemia, hypertension, obesity, pesticides, pollution, physical inactivity, sleep disruption, smoking) and by pathogens, directly or via olfactory routes to basal-forebrain BBB control centers. The BBB benefits from statins, NSAIDs, estrogen, melatonin, memantine, and the Mediterranean diet. Polymicrobial involvement is supported by upregulation of bacterial, viral, and fungal sensors/defenders in the AD brain, blood, or cerebrospinal fluid. AD serum amyloid-beta autoantibodies may attenuate its antimicrobial effects favoring microbial survival and cerebral invasion leading to activation of neurodestructive immune/inflammatory processes, which may also be augmented by age-related immunosenescence. AD may thus respond to antibiotic, antifungal, or antiviral therapy.
30480234	88	98	Disruption	Disease	MESH:D019958
30480234	158	177	Alzheimer's Disease	Disease	MESH:D000544
30480234	213	232	Alzheimer's disease	Disease	MESH:D000544
30480234	234	236	AD	Disease	MESH:D000544
30480234	282	284	AD	Disease	MESH:D000544
30480234	434	450	Candida albicans	Species	5476
30480234	452	475	Cryptococcus neoformans	Species	5207
30480234	477	487	Bornavirus	Species	186458
30480234	489	510	Borrelia burgdorferri	Species	
30480234	512	527	cytomegalovirus	Species	10358
30480234	529	540	Ebola virus	Species	186536
30480234	542	547	HSV-1	Species	10298
30480234	549	555	HERV-W	Species	87786
30480234	557	562	HIV-1	Species	11676
30480234	564	576	Epstein-Barr	Species	
30480234	578	589	hepatitis C	Species	11103
30480234	591	600	influenza	Disease	MESH:D007251
30480234	602	622	Chlamydia pneumoniae	Species	83558
30480234	624	648	Porphyrymonas gingivalis	Species	
30480234	650	669	Helicobacter pylori	Species	210
30480234	671	688	Toxoplasma gondii	Species	5811
30480234	690	707	Trypanosoma cruzi	Species	5693
30480234	748	750	AD	Disease	MESH:D000544
30480234	823	825	AD	Disease	MESH:D000544
30480234	944	946	AD	Disease	MESH:D000544
30480234	1091	1093	AD	Disease	MESH:D000544
30480234	1094	1102	patients	Species	9606
30480234	1147	1152	APOE4	Gene	348
30480234	1236	1255	tropical infections	Disease	MESH:D007239
30480234	1260	1272	hepatitis C.	Disease	MESH:D019698
30480234	1280	1292	inflammatory	Disease	MESH:D007249
30480234	1321	1326	APOE4	Gene	348
30480234	1328	1331	CR1	Gene	1378
30480234	1337	1342	TREM2	Gene	54209
30480234	1353	1355	AD	Disease	MESH:D000544
30480234	1437	1439	AD	Disease	MESH:D000544
30480234	1459	1466	alcohol	Chemical	MESH:D000438
30480234	1468	1476	aluminum	Chemical	MESH:D000535
30480234	1478	1488	concussion	Disease	MESH:D001924
30480234	1490	1512	cerebral hypoperfusion	Disease	MESH:D002547
30480234	1514	1522	diabetes	Disease	MESH:D003920
30480234	1524	1536	homocysteine	Chemical	MESH:D006710
30480234	1538	1558	hypercholesterolemia	Disease	MESH:D006937
30480234	1560	1572	hypertension	Disease	MESH:D006973
30480234	1574	1581	obesity	Disease	MESH:D009765
30480234	1615	1625	inactivity	Disease	MESH:C564765
30480234	1633	1643	disruption	Disease	MESH:D019958
30480234	1794	1803	melatonin	Chemical	MESH:D008550
30480234	1805	1814	memantine	Chemical	MESH:D008559
30480234	1956	1958	AD	Disease	MESH:D000544
30480234	1997	1999	AD	Disease	MESH:D000544
30480234	2006	2018	amyloid-beta	Gene	351
30480234	2173	2185	inflammatory	Disease	MESH:D007249
30480234	2258	2260	AD	Disease	MESH:D000544
30480234	Association	MESH:D019698	1378
30480234	Association	MESH:D019698	348
30480234	Association	MESH:D000544	351
30480234	Association	MESH:D006710	MESH:D000544
30480234	Negative_Correlation	MESH:D007239	348
30480234	Positive_Correlation	MESH:D007249	348
30480234	Association	MESH:D007249	1378
30480234	Positive_Correlation	MESH:D000438	MESH:D000544
30480234	Association	MESH:D019698	54209
30480234	Association	MESH:D007249	351
30480234	Association	MESH:D000535	MESH:D000544
30480234	Association	MESH:D007249	54209

